The intersection of business, science, and the law poses unique challenges for life sciences companies. Morgan Lewis understands the ramifications of that critical connection, and our lawyers work efficiently and strategically to solve the business, transactional, regulatory, intellectual property, litigation, and related issues our clients encounter throughout the product life cycle.

Our global life sciences capabilities were developed specifically to serve the pharmaceutical, biotechnology, medical device, and related industries, as well as the entities that invest in them, such as venture capital and private equity funds.